Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ivan V. Semenyuta
Observed names:
I. Semenyuta,
I. V. Semenyuta,
Ivan Semenuta,
Ivan Semenyuta,
Semenyuta Ivan,
Semenyuta, Ivan,
Семенюта, И.В.
show all 7
Institutions:
National Academy of Sciences of Ukraine,
Institute of Bioorganic Chemistry and Petrochemistry V.P. Kukhar
Observed institutions:
National Academy of Sciences of Ukraine,
National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute”,
Institute of Bioorganic Chemistry and Petrochemistry V.P. Kukhar
ORCID:
0000-0001-8464-3692
Observed ORCID:
0000-0001-8464-3692
OpenAlex ID:
A5089571276
Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents
2018
·
Maryna V. Kachaeva
, Diana M. Hodyna
, et al.
·
Computational Biology and Chemistry
·
76
1,3-Oxazole derivatives as potential anticancer agents: Computer modeling and experimental study
2016
·
Ivan Semenyuta
, Vasyl Kovalishyn
, et al.
·
Computational Biology and Chemistry
·
50
Imidazolium ionic liquids as effective antiseptics and disinfectants against drug resistant S. aureus: In silico and in vitro studies
2018
·
Diana Hodyna
, Vasyl Kovalishyn
, et al.
·
Computational Biology and Chemistry
·
35
eDNA Inactivation and Biofilm Inhibition by the PolymericBiocide Polyhexamethylene Guanidine Hydrochloride (PHMG-Cl)
2022
·
Olena V. Moshynets
, Taras P. Baranovskyi
, et al.
·
International Journal of Molecular Sciences
·
33
PDF
Synthesis, spectroscopic and molecular docking studies of imidazolium and pyridinium based ionic liquids with HSA as potential antimicrobial agents
2017
·
Maria M. Trush
, Ivan V. Semenyuta
, et al.
·
Journal of Molecular Structure
·
33
Reduced ecotoxicity and improved biodegradability of cationic biocides based on ester-functionalized pyridinium ionic liquids
2018
·
Maria Trush
, Larysa Metelytsia
, et al.
·
Environmental Science and Pollution Research
·
32
Design of (quinolin-4-ylthio)carboxylic acids as new Escherichia coli DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing
2020
·
Larysa Metelytsia
, Diana Hodyna
, et al.
·
Computational Biology and Chemistry
·
31
Synthesis, in silico and in vitro Evaluation of Novel Oxazolopyrimidines as Promising Anticancer Agents
2020
·
Yevheniia Velihina
, Thomas Scattolin
, et al.
·
Helvetica Chimica Acta
·
23
Functionalized imidazolium-based ionic liquids: biological activity evaluation, toxicity screening, spectroscopic, and molecular docking studies
2020
·
Maria M. Trush
, Ivan V. Semenyuta
, et al.
·
Medicinal Chemistry Research
·
23
Theoretical and Experimental Studies of Phosphonium Ionic Liquids as Potential Antibacterials of MDR Acinetobacter baumannii
2022
·
Larysa O. Metelytsia
, Diana M. Hodyna
, et al.
·
Antibiotics
·
18
PDF
Structure-Activity Relationship Modeling and Experimental Validation of the Imidazolium and Pyridinium Based Ionic Liquids as Potential Antibacterials of MDR Acinetobacter baumannii and Staphylococcus aureus
2021
·
Ivan V. Semenyuta
, Maria M. Trush
, et al.
·
International Journal of Molecular Sciences
·
18
PDF
Rational design of isonicotinic acid hydrazide derivatives with antitubercular activity: Machine learning, molecular docking, synthesis and biological testing
2018
·
Vasyl Kovalishyn
, Julie Grouleff
, et al.
·
Chemical Biology & Drug Design
·
18
Predictive QSAR modeling of phosphodiesterase 4 inhibitors
2011
·
Vasyl Kovalishyn
, Vsevolod Tanchuk
, et al.
·
Journal of Molecular Graphics and Modelling
·
16
1,3-Oxazole derivatives of cytisine as potential inhibitors of glutathione reductase of Candida spp.: QSAR modeling, docking analysis and experimental study of new anti-Candida agents
2020
·
Larysa O. Metelytsia
, Maria M. Trush
, et al.
·
Computational Biology and Chemistry
·
14
New QSTR models to evaluation of imidazolium- and pyridinium-contained ionic liquids toxicity
2024
·
Ivan Semenyuta
, Vasyl Kovalishyn
, et al.
·
Computational Toxicology
·
11
Undecylenic acid and N,N-dibutylundecenamide as effective antibacterials against antibiotic-resistant strains
2023
·
Y. D. Startseva
, D. M. Hodyna
, et al.
·
The Ukrainian Biochemical Journal
·
11
PDF
Anticancer activity features of imidazole-based ionic liquids and lysosomotropic detergents: in silico and in vitro studies
2024
·
Anastasiia Gryniukova
, Petro Borysko
, et al.
·
Molecular Diversity
·
10
PDF
In silico study of 4-phosphorylated derivatives of 1,3-oxazole as inhibitors of Candida albicans fructose-1,6-bisphosphate aldolase II
2019
·
Ivan V. Semenyuta
, Oleksandr L. Kobzar
, et al.
·
Heliyon
·
10
PDF
Design, synthesis and anticancer activity of novel 4-(5-amino-4-cyano-1,3-oxazol-2-yl)benzenesulfonamide derivative
2024
·
Oleksandr Severin
, Stepan Pilyo
, et al.
·
Current Chemistry Letters
·
9
PDF
Design and experimental validation of the oxazole and thiazole derivatives as potential antivirals against of human cytomegalovirus
2023
·
V. Kovalishyn
, O. Severin
, et al.
·
SAR and QSAR in environmental research
·
9
PDF
A new generation of N-heterocyclic carbene (NHC) gold–selenolato complexes as potent anticancer agents: distinct synthetic routes and evaluation in 2D and 3D cancer models
2025
·
Pierre Arnaut
, Nestor Bracho Pozsoni
, et al.
·
Chemical Science
·
8
PDF
Synthesis, Characterization and in vitro Anticancer Evaluation of 5‐Sulfinyl(sulfonyl)‐4‐arylsulfonyl‐Substituted 1,3‐Oxazoles
2023
·
Vladimir Zyabrev
, Stepan Pilyo
, et al.
·
ChemMedChem
·
8
PDF
New anti-candida active nitrogen-containing bisphosphonates as inhibitors of farnesyl pyrophosphate synthase Candida albicans
2019
·
L. O. Metelytsia
, D. M. Hodyna
, et al.
·
The Ukrainian Biochemical Journal
·
8
PDF
Synthesis, QSAR modeling, and molecular docking of novel fused 7‐deazaxanthine derivatives as adenosine A 2A receptor antagonists
2021
·
Liubov V. Muzychka
, Evgenii V. Verves
, et al.
·
Chemical Biology & Drug Design
·
7
Hybrid Design of Isonicotinic Acid Hydrazide Derivatives: Machine Learning Studies, Synthesis and Biological Evaluation of their Antituberculosis Activity
2019
·
Vasyl Kovalishyn
, Diana Hodyna
, et al.
·
Current Drug Discovery Technologies
·
7
Show more works
View as search
Works count:
54
Citation count:
560
H-index:
14
I10-index:
18
Year
Topic
Type